About Trinean
Trinean is a company based in Gentbrugge (Belgium) founded in 2006 was acquired by Unchained Labs in June 2017. Trinean has raised $9.45 million across 4 funding rounds from investors including Unchained Labs, European Union and Capricorn Partners. Trinean offers products and services including Aunty, Stunner, Honeybun, Lunatic, and Leprechaun. Trinean operates in a competitive market with competitors including Impedimed, Rigaku, Speclipse, Anvajo and Ahura Scientific, among others.
- Headquarter Gentbrugge, Belgium
- SectorsHealthcare
- Website trinean.com
- Social LinkedIn X
- Acquired by Unchained Labs (Jun 2017)
- Legal Name Unchained Labs
- Total Equity Funding$9.45M (USD)
in 4 rounds
- Latest Funding Round$690.68K (USD), Grant
Jan 2015
- InvestorsUnchained Labs
& 5 more
- Acquired byUnchained Labs
(Jun 2017)
Products & Services of Trinean
Trinean offers a comprehensive portfolio of products and services, including Aunty, Stunner, Honeybun, Lunatic, and Leprechaun.
High-throughput instrument for protein stability characterization.
Device for protein and nucleic acid quantification and sizing.
Rapid viscometer for analyzing sample viscosity in research.
System for next-generation protein and nucleic acid quantification.
Tool for lentivirus and exosome characterization in therapy.
Funding Insights of Trinean
Trinean has successfully raised a total of $9.45M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $690.68 thousand completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.45M
- Total Rounds 4
- Last Round Grant — $690,682
- First Round $4.6M
(Oct 2008)
- Investors Count 5
All 4 funding rounds of Trinean with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | $690,682 | Grant | – | – | |
| May 2013 | $1.29M | Series A | – | – | |
| Apr 2012 | $3.56M | Series A | – | – | |
| Oct 2008 | $4.6M | Series A | – | – |
6 investors in total: 6 institutional.
Investors in Trinean
Trinean has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Unchained Labs, European Union and Capricorn Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed by Capricorn Partners into European tech ventures. | 1993 | capricorn.be | Leuven, Belgium | |
Life sciences-focused VC firm investing in Europe and Canada | 2007 | vesaliusbiocapital.com | Strassen, Luxembourg | |
US focused early-stage VC firm | – | cap-e.com | Washington, Dc, United States | |
- | – | baekelandfonds.be | - | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Multiplex protein stability platform for biologics is developed. | 2015 | unchainedlabs.com | Pleasanton, United States |
Investor details for Trinean
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Trinean
4 dated milestones of Trinean across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Trinean is founded.
- Funding First funding round of $4.6M.
- Funding Latest funding round, Grant, of $691K.
- Exit Acquired by Unchained Labs.
Competitors of Trinean
Trinean operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Impedimed, Rigaku, Speclipse, Anvajo and Ahura Scientific, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| impedimed.com | 1999 | Carlsbad, United States | $3.44M | 76 | Technologies for non-invasive fluid status assessment and monitoring are developed. | |
| rigaku.com | 1951 | Tokyo, Japan | – | 293 | XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided. | |
| speclipse.com | 2015 | Seongnam-si, South Korea | $10.55M | – | Molecular spectroscopy systems for early skin cancer detection are provided. | |
| anvajo.com | 2016 | Dresden, Germany | $17.32M | 66 | Point-of-care solutions for laboratory diagnostics are provided by Anvajo. | |
| ahurascientific.com | 2002 | Wilmington, United States | $17M | – | Optical systems are developed for identifying solid and liquid chemicals. | |
| spectra-analysis.com | 2004 | Boston, United States | $9.25M | 6 | Infrared spectroscopic instruments are provided for molecular analysis. | |
| lineardiagnostics.com | 2011 | Birmingham, United Kingdom | $4.08M | 4 | Molecular diagnostic tests for sexually transmitted infections are developed. | |
| magritek.com | 2004 | Wellington, New Zealand | – | – | Provider of NMR and MRI solutions for industries and research laboratories | |
| imspex.com | 2011 | Abercynon, United Kingdom | $2.23M | 5 | Analytical instruments for diagnostics and industrial applications |
Detailed competitors of Trinean
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Trinean
Complete news archive for Trinean
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Trinean
10 companies that operate in the same segment as Trinean (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Trinean
Trinean was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Trinean is headquartered in Gentbrugge, Belgium. It is registered at Gentbrugge, East Flanders, Belgium.
Trinean is a funded company, having raised a total of $9.45M across 4 funding rounds to date. The company's 1st funding round was a Series A of $4.6M, raised on Oct 2008.
Trinean was founded in 2006 in Gentbrugge, Belgium, where UVVIS spectrometry solutions are developed for the biotechnology sector. Products such as the DropSense96 spectrophotometer and the Xpose micro-volume spectrometer are utilized for spectral analysis and quantification of microliter samples including DNA, RNA, and proteins. Spectral content profiling software is also offered to complement these devices in laboratory operations.
Trinean's top competitors include Impedimed, Linear Diagnostics and Anvajo.
Trinean offers Aunty, Stunner, Honeybun, Lunatic, and Leprechaun.
Trinean has 6 investors. Key investors include Unchained Labs, European Union, Capricorn Partners, Vesalius Biocapital Partners, and Cap-E.
Trinean operates through Unchained Labs.
Yes. Trinean was acquired by Unchained Labs in June 2017.